Continental variations in IgA nephropathy among Asians

Clinical Nephrology

Volumn 70, Issue 5, 2008, Pages 377-384

  Prakash, Suma ^a,b   Kanjanabuch, T ^c,d   Austin, P C ^b,e   Croxford, R ^e   Hsu, C Y ^a   Choi, A I ^a   Cattran, D C ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY HEALTH NETWORK   (Canada)

^c KING CHULALONGKORN MEMORIAL HOSPITAL   (Thailand)

^d CHULALONGKORN UNIVERSITY   (Thailand)

^e INSTITUTE FOR CLINICAL EVALUATIVE SCIENCES   (Canada)

Author keywords

Asians; Clinical presentation; Geographical variation; IgA nephropathy; Renal function

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; AZATHIOPRINE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; IMMUNOSUPPRESSIVE AGENT; PREDNISONE;

ADULT; AGE; ARTICLE; ASIAN; BODY MASS; CANADA; CHRONICITY; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; GENDER; GEOGRAPHY; GLOMERULUS FILTRATION RATE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOGLOBULIN A NEPHROPATHY; MAJOR CLINICAL STUDY; MALE; MEAN ARTERIAL PRESSURE; PROTEINURIA; RETROSPECTIVE STUDY; THAILAND;

EID: 56749131313     PISSN: 03010430     EISSN: None     Source Type: Journal    
DOI: 10.5414/cnp70377     Document Type: Article

References (31)

1. Bartosik LP, Lajoie G, Sugar L, Cattran DC. Predicting progression in IgA nephropathy. Am J Kidney Dis. 2001; 38: 728-735.
2. Berger J. IgA glomerular deposits in renal disease. Transplant Proc. 1969; 1: 939-944.
3. Cattran DC, Reich HN, Beanlands HJ, Miller JA, Scholey JW, Troyanov S; for the Genes Gender and Glomerulonephritis Group. The impact of sex in primary glomerulonephritis. Nephrol Dial Transplant. 2008; Jan 8 Epub ahead of print.
4. Chow KM, Wong TYH, Li PK. Genetics of common progressive renal disease. Kidney Int. 2005; 67 (Suppl): S41-S45.
5. Donadio JV, Grande JP. IgA nephropathy. N Engl J Med. 2002; 347: 738-748.
6. Gandolfo MT, Verzola D, Salvatore F, Gianiorio G, Procopio V, Romagnoli A, Giannoni M, Garibotto G. Gender and the progression of chronic renal diseases: does apoptosis make the difference? Minerva Urol Nefrol. 2004; 56: 1-14.
7. Geddes CC, Rauta V, Gronhagen-Riska C, Bartosik LP, Jardine AG, Ibels LS, Pei Y, Cattran DC. A tricontinental view of IgA nephropathy. Nephrol Dial Transplant. 2003; 18: 1541-1548.
8. Ginsberg JM, Chang BS, Matarese RA, Garella S. Use of single voided urine samples to estimate quantitative proteinuria. N Engl J Med. 1993; 309: 1543-1546.
9. Haas M. Histologic subclassification of IgA nephropathy: A clinicopathologic study of 244 cases. Am J Kidney Dis. 1997; 29: 829-842.
10. Hall YN, Fuentes EF, Chertow GM, Olson JL. Race/ethnicity and disease severity in IgA nephropathy. BMC Nephrol. 2004; 5: 10.
11. Horita Y, Tadokoro M, Taura K, Ashida R, Hiu M, Taguchi T, Furusu A, Kohno S. Predivisolone co-administered with losartan confers renoprotection in patients with IgA nephropathy. Ren Fail. 2007; 29: 441-446.
12. Hsu SI, Ramirez SB, Winn MP, Bonventre JV, Owen WF. Evidence for genetic factors in the development and progression of IgA nephroapthy. Kidney Int. 2000; 57: 1818-1835.
13. Kobayashi Y, Hiki Y, Kokubo T, Horii A, Tateno S. Steroid therapy during the early stage of progressive IgA nephropathy. A 10-year follow-up study. Nephron. 1996; 72: 237-242.
14. Levy M, Berger J. Worldwide perspective of IGA nephropathy. Am J Kidney Dis. 1988; 12: 340-347.
15. Li PK, Ho KK, Szeto CC, Yu L, Lai FM. Prognostic indicators of IgA nephropathy in the Chinese - clinical and pathological perspectives. Nephrol Dial Transplant. 2002; 17: 64-69.
16. Milovanceva-Popovska M, Grcevska L, Dzikova S, Ristovska V, Nikolov V, Polenakovic M. IgA nephropathy: 23 years offollow-up. Prilozi. 2006; 27: 13-27.
17. Neugarten J, Acharya A, Silbiger SR. Effect of gender on the progression of nondiabetic renal disease: A meta-analysis. J Am Soc Nephrol. 2000; 11: 319-329.
18. Nieuwhof C, Kruytzer M, Frederiks P, van Breda Vriesman PJ. Chronicity index and mesangial early IgA nephropathy. Am J Kidney Dis. 1998; 31: 962-970.
19. Obara W, Iida A, Suzuki Y, Tanaka T, Akiyama F, Maeda S, Ohnishi Y, Yamada R, Tsunoda T, Takei T, Ito K, Honda K, Uchida K, Tsuchiya K, Yumura W, Ujiie T, Nagane Y, Nitta K, Miyano S, Narita I, Gejyo F, Fujioka T, Nihei H, Nakamura Y. Association of single-nucleotide polymorphisms in the polymeric immunoglobulin receptor gene with immunoglobulin A nephropathy (IgAN) in Japanese patients. J Hum Genet. 2003; 48: 293-299.
20. Pozzi C, Bolasco PG, Fogazzi GB, Andrulli S, Altieri P, Ponticelli C, Locatelli F. Corticosteroids in IgA nephropathy: A randomised controlled trial. Lancet. 1999; 353: 883-887.
21. Praga M, Gutierrez E, Gonzalez E, Morales E, Hernandez E. Treatment of IgA nephropathy with ACE inhibitors: A randomized and controlled trial. J Am Soc Nephrol. 2003; 14: 1578-1583.
22. Riansuwan T, Kanjanabuch T, Lewsuwan S, Eiam-Ong S. Clinical characteristics and histopathological findings in 120 IgA nephropathy patients in Thailand. J Med Assoc Thai. 2006; 89 (Suppl 2): S163-S167.
23. Stengel B, Couchoud C, Cenee S, Hemon D. Age, blood pressure and smoking effects on chronic renal failure in primary glomerular nephropathies. Kidney Int. 2000; 57: 2519-2526.
24. Stewart JH, McCredie MR, McDonald SP. Incidence of end-stage renal disease in overseas-born, compared with Australian-born, non-indigenous Australians. Nephrology (Carlton). 2004; 9: 247-252.
25. Szeto CC, Lai FM, To KF, Wong TY, Chow KM, Choi PC, Lui SF, Li PK. The natural history of immunoglobulin A nephropathy among patients with hematuria and minimal proteinuria. Am J Med. 2001; 110: 434-437.
26. The Nephrology Society of Thailand. Tahiland Renal Replacemtn Therapy Registry (TRT Registry); 2003. http://www.nephrothai.org/trt/ TRT%20Web.files/frame.htm
27. To KF, Choi PC, Szeto CC, Li PK, Tang NL, Leung CB, Wang AY, Ho KK, Wong TY, Lui SF, Lai FM. Outcome of IgA nephropathy in adults graded by chronic histological lesions. Am J Kidney Dis. 2000; 35: 392-400.
28. Wetzels JF, Kiemeney LA, Swinkels DW, Willems HL, den Heijer M. Age- and gender-specific reference values of estimated GFR in Caucasians: The Nijmegen biomedical study. Kidney Int. 2007; 72: 632-637.
29. Woo KT, Chiang GS, Pull A, Tan PH, Lau YK, Chin YM. The changing pattern of glomerulonephritis in Singapore over the past two decades. Clin Nephrol. 1999; 52: 96-102.
30. Xia YF, Huang S, Li X, Yang N, Huang J, Xue C, Zhang M, Leung JCK, Lam MF, Li J. A family-based association study of megsin A23167G polymorphism with susceptibility and progresson of IgA nephropathy in a Chinese population. Clin Nephrol. 2006; 3: 153-159.
31. Yu L, Guo R, Li H, Xie X, Jiang N, Zhao W, Feng X. The pathologic and epidemic characteristics of 618 cases of IgA nephropathy in Shaanxi area. Journal of Xi'An Jiatong University (Medical Sciences). 2005; 26: 450-453.